Kennedy Capital Management’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-39,526	Closed	-$335K	–	734
2024 Q2	$335K	Buy	39,526 +1,324	+3%	+$11.2K	0.01%	654
2024 Q1	$343K	Buy	38,202 +1,359	+4%	+$12.2K	0.01%	674
2023 Q4	$414K	Buy	+36,843	New	+$414K	0.01%	641